Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GNP is a South Korean biotechnology and medical device company specializing in the development and manufacture of aesthetic and therapeutic products. The company is best known for its extensive portfolio of dermal fillers, including the GANA Fill and GANA HA lines, which utilize advanced formulations of poly-L-lactic acid (PLLA) and hyaluronic acid. Beyond aesthetics, GNP develops medical devices and biomaterials for orthopedic applications, such as treatments for osteoarthritis. The company maintains a strong focus on research and development to enhance the longevity and safety of injectable treatments. GNP's products are distributed globally, catering to the growing demand for minimally invasive cosmetic procedures and regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GNP.